Table 2.
Operation | No (%) | Age (years) | Euroscore | CPB (mins) | XClamp (mins) | Mortality |
---|---|---|---|---|---|---|
MVR |
15 (29.4%) |
33.2 ± 11.4 |
3.9 ± 1.3 |
145.5 ± 41.1 |
96.3 ± 20.6 |
2 |
MV Rep |
1 (2%) |
21 |
3 |
120 |
80 |
0 |
ASD |
14 (27.5%) |
28.9 ± 12.4 |
2.9 ± 0.9 |
86.5 ± 44.2 |
45.9 ± 29.8 |
1 |
VSD |
8 (15.7%) |
15.0 ± 9.4 |
3.9 ± 1.2 |
159.1± 77.3 |
108.9 ± 64.7 |
2 |
AVR |
5 (9.8%) |
23.8 ± 3.1 |
4.0 ± 1.4 |
156.8 ± 10.8 |
103.5 ± 20 |
0 |
Glenn |
2 (3.9%) |
13 ± 2.8 |
2.5 ± 0.7 |
97 ± 1.4 |
N/A |
0 |
LA Myxoma |
2 (3.9%) |
60 ± 14.1 |
7 ± 4.3 |
132 ± 11.3 |
98 ± 2.8 |
1 |
TOF |
2 (3.9%) |
15.5 ± 13.4 |
2 |
267.5 ± 19.1 |
127 ± 15.6 |
2 |
CABG |
2 (3.9%) |
64 ± 11.3 |
10 ± 5.7 |
160 |
70 |
1 |
TOTAL | 51 | 9 |
MVR: Mitral Valve Replacement, MV Rep Mitral Valve Repair, ASD Atrial Septal Defect, VSD Ventricular Septal Defect, AVR Aortic Valve Replacement, Glenn Bidirectional Glenn Shunt, LA Myxoma, Left Atrial Myxoma, TOF Tetralogy of Fallot, CABG Coronary Artery Bypass Grafting, CPB Cardiopulmonary Bypass time, Xclamp Aortic Cross Clamp time.